Hazard Hub
Product quality Recalls in Canada — Page 2
347 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.
Showing 31–60 of 347
Lancora Tablets; Broken / partial tablets in blister pack
Product quality
View recall details →
BD Canada ChloraPrep product recall; Sterility concerns
Product quality
View recall details →
Hizentra: The appearance is out of specification in the affected lot.
Product quality
View recall details →
Kirkland Signature Women 50+: may contain the presence of foreign matter (metal fragments)
Product quality
View recall details →
Personnelle Supravite Energizing Formula: The breakage of vials can generate glass fragments
Product quality
View recall details →
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised.
Product quality
View recall details →
Honibe Honey Gummies - Melatonin: Daily recommended intake may cause the active ingredient to exceed the allowable limit.
Product quality
View recall details →
GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients
Product quality
View recall details →
PMS-BUSULFAN 6mg/mL: impurity could be out of specification
Product quality
View recall details →
Max Slim Alpha-GPC + Citicoline: The affected lot contains an undeclared ingredient (caffeine)
Product quality
View recall details →
SUVEXX: The assay is out of specification in the affected lot.
Product quality
View recall details →
Health First Vitamin E capsule; Undeclared active ingredient
Product quality
View recall details →
Moxifloxacin : assay out of trend
Product quality
View recall details →
VENLAFAXINE XR: out of specification
Product quality
View recall details →
KETOROLAC: The weight is out of specification in the affected lots.
Product quality
View recall details →
CEFAZOLIN FOR INJECTION : Vials may be underfilled in the affected lot.
Product quality
View recall details →
Teva-Indomethacin: Out of specification
Product quality
View recall details →
APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution
Product quality
View recall details →
Seasonique and Seasonale birth control pills are being recalled due to the possibility of a missing blister card
Product quality
View recall details →
Seasonique, Seasonale tablets: Affected lot(s) may not contain the correct amount of tablets (missing blister card)
Product quality
View recall details →
TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution
Product quality
View recall details →
BiOptimizers Magnesium Breakthrough capsules; Residue on capsules
Product quality
View recall details →
Teva Octreotide for injectable suspension recalled due to potential drug quality issues
Product quality
View recall details →
Octreotide for injectable suspension; Good manufacturing practices concerns
Product quality
View recall details →
Locametz powder for solution, kit; Out of specification (unknown impurity)
Product quality
View recall details →
JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)
Product quality
View recall details →
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromised
Product quality
View recall details →
Viazen Immunity: The selenium content is out of specification in the affected batch.
Product quality
View recall details →
Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.
Product quality
View recall details →
APO-TRAVOPROST-TIMOP PQ: missing the documented justification for the results obtained.
Product quality
View recall details →